Evidence map›Paper›PMID 40171191›Full record

ArticleFrontiers in endocrinology2025

Hypothyroidism monitoring and control during the first trimester of pregnancy in Catalonia.

Glòria Tena Vivó, Oriol Cunillera Puértolas, Mercè Albareda Riera, Neus Parellada Esquius, Mònica Isidro Albaladejo, Gemma Rodríguez Palomar, Silvia Palmero Aliste, Lluís Vila

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Glòria Tena VivóHospital de Viladecans, Obstetrics and Gynecology Viladecans, Barcelona, Spain.
Oriol Cunillera PuértolasUnitat de Suport a la Recerca Metropolitana Sud, Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina, l'Hospitalet de Llobregat, Catalunya, Spain.
Mercè Albareda RieraEndocrinology and Nutrition Division, Hospital de Sant Joan Despí Moisès Broggi, Sant Joan Despí, Spain.
Neus Parellada EsquiusInstitut Català de la Salut Gerència Territorial Metropolitana Sud, Epidemiology and Research, L'Hospitalet de Llobregat, Catalunya, Spain.
Mònica Isidro AlbaladejoInstitut Català de la Salut (ICS), Sexual and Reproductive Primary Health Care, Sant Boi de Llobregat, Spain.
Gemma Rodríguez PalomarServei d'Atenció Primària Delta del Llobregat Gerència Territorial Metropolitana Sud, Pharmacologist, L'Hospitalet de Llobregat, Catalunya, Spain.
Silvia Palmero AlisteInstitut Català de la Salut (ICS), Sexual and Reproductive Primary Health Care, Sant Boi de Llobregat, Spain.
Lluís VilaEndocrinology and Nutrition Division, Hospital de Sant Joan Despí Moisès Broggi, Sant Joan Despí, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study aims to describe hypothyroidism monitoring and control during the first trimester of pregnancy in women with known hypothyroidism in Catalonia. Materials and methods: Pregnancies registered in primary care in Catalonia between 2014 and 2016 were retrospectively studied. Women with hypothyroidism were selected for the study. Hypothyroidism was defined if, on the date of the last menstrual period (LMP), there was an updated thyroid hormone prescription (code ATC H03AA -levothyroxine) or any of the following active diagnostic codes: ICD-10: E02, E03, E89.0. To evaluate hypothyroidism monitoring and control, thyrotropin (TSH) tests during the first trimester of pregnancy were considered and categorized according to the reference values of each laboratory. Results: Out of 111,811 pregnancies, 5,574 had known hypothyroidism. TSH was evaluated in 3,158 (56.65%) of them. The TSH values were within the recommended ranges in 1,146 (36.3%) of the cases, being low abnormal in 53 of them (1.7%) and high abnormal in 1,959 (62%). Conclusion: TSH testing was not evaluated in almost half of the pregnant women with known hypothyroidism in primary care services in Catalonia during the pregnancy first trimester. Among those tested, more than two-thirds had TSH levels outside the target range. This means that it is essential to improve the management of hypothyroidism during the first trimester of pregnancy in Catalonia.

Indexed as

HypothyroidismPregnancy ComplicationsPregnancy Trimester, FirstAdultFemaleHumansPregnancyRetrospective StudiesSpainThyroid Function TestsThyrotropinThyroxineYoung AdultThyrotropinThyroxinehypothyroidismhypothyroidism controlhypothyroidism monitoringpregnancyprevalence

Identifiers

PMID40171191
PMCPMC11958182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.